- The strongest ingredient-level evidence is for food, not pills: a dose-response meta-analysis found every 10 g/day increase in dietary fiber was associated with a 10% lower colorectal cancer risk (RR 0.90), and three daily servings of whole grains were linked to a 17% lower risk (RR 0.83).
- A 47-trial meta-analysis (commissioned by WHO's Nutrition Guidance Advisory Group) found long-chain omega-3 supplements had little or no effect on cancer diagnosis (RR 1.02) or cancer death (RR 0.97).
- A systematic review of randomized cancer trials concluded curcumin is not effective in blocking or slowing cancer progression, and Cochrane found green tea/EGCG evidence inconsistent and low-certainty, with extracts causing GI effects and liver-enzyme elevations in trials.
- Cochrane found no RCT evidence supporting laetrile/amygdalin ("vitamin B17," including apricot-kernel products) for cancer treatment, and judged the risk-benefit balance unambiguously negative because of cyanide poisoning risk.
- A BMJ Open systematic review found zero randomized trials and zero studies of alkaline water for cancer treatment — a complete absence of evidence, not just weak evidence.
The most evidence-supported “cancer ingredients” are not cancer-treatment pills: dietary fiber and whole grains have strong prospective evidence for lower colorectal cancer risk, while cruciferous vegetables have moderate observational and mechanistic support, especially for sulforaphane and related isothiocyanates (BMJ fiber meta-analysis, cruciferous vegetable meta-analysis). Vitamin D did not reduce overall invasive cancer incidence in the large VITAL randomized trial, although a secondary analysis found fewer advanced cancers, especially in normal-weight participants (VITAL primary trial, VITAL advanced-cancer analysis). Green tea, curcumin, and omega-3 are popular, but independent reviews do not prove them as cancer-prevention supplements (Cochrane green tea review, curcumin RCT review, omega-3 randomized-trial meta-analysis). Laetrile/B17, apricot kernels, hydrogen peroxide or oxygen therapies, Gerson therapy, Essiac tea, graviola, and alkaline water should not replace oncology care; several have no controlled evidence and can cause serious harm (Cochrane laetrile review, NCI Gerson PDQ, BMJ Open alkaline-water review).
Table of Contents
- Evidence summary
- The cancer ingredient evidence map
- Ingredients with the best independent evidence for risk reduction
- Popular cancer ingredients that are unproven, debunked, or dangerous
- What works and what does not
- Side effects and interactions
- Funding and conflict review
- Frequently asked questions
- Sources
Evidence summary
| Claim | Best independent evidence | Source country / scope | Funding and conflict check | Grade |
|---|---|---|---|---|
| More dietary fiber and whole grains lower colorectal cancer risk. | Prospective-dose response meta-analysis: every 10 g/day increase in total dietary fiber was associated with RR 0.90 for colorectal cancer; three additional daily servings of whole grains were associated with RR 0.83. | International cohorts; UK-led analysis. | Funded by World Cancer Research Fund Continuous Update Project; BMJ disclosure reported no financial relationships with interested organizations. | Strong for foods BMJ |
| Cruciferous vegetables may reduce colorectal cancer risk. | Meta-analysis of 35 observational studies reported RR 0.82 for high versus low cruciferous vegetable intake and colorectal cancer risk. | International studies; China/US authorship. | Public academic and NIH-linked training support; authors declared no conflicts. | Moderate PMC |
| Sulforaphane supplements prevent cancer. | Human evidence is mainly mechanistic and biomarker-focused; cancer-incidence proof for supplements is lacking. | Global literature. | Academic mechanistic literature; commercial sprout/extract claims are often extrapolations from non-outcome studies. | Not proven as a supplement PMC |
| Vitamin D prevents cancer. | VITAL: vitamin D3 2,000 IU/day did not lower invasive cancer incidence (HR 0.96; 95% CI 0.88–1.06), but a secondary analysis found lower advanced cancer incidence. | United States randomized trial. | NIH-funded; vitamin D/placebo materials were donated by Pharmavite and packaging support was disclosed, so supplement-material conflict is noted but the primary result was null. | Mixed PubMed |
| Green tea or EGCG prevents cancer. | Cochrane found inconsistent results and low-certainty evidence; green-tea extracts caused gastrointestinal effects and liver-enzyme elevations in trials. | International review. | Cochrane review; included trials had mixed public, charity, and some pharmaceutical/company funding. | Inconclusive Cochrane/PMC |
| Curcumin slows or treats cancer. | Systematic review of cancer RCTs concluded curcumin is not effective in blocking or slowing cancer progression based on limited, heterogeneous trials. | International review. | No external funding; authors declared no conflict of interest. | Not proven PMC |
| Omega-3 supplements prevent cancer. | Meta-analysis of 47 RCTs found long-chain omega-3 had little or no effect on cancer diagnosis (RR 1.02; 95% CI 0.98–1.07) or cancer death (RR 0.97; 95% CI 0.90–1.06). | International randomized trials. | Commissioned and funded by WHO NUGAG; authors reported no interested-organization financial relationships. | Does not work for prevention British Journal of Cancer |
| Laetrile/B17/apricot kernels treat cancer. | Cochrane found no RCT or quasi-RCT evidence supporting laetrile/amygdalin and judged the risk-benefit balance unambiguously negative because of cyanide poisoning risk. | International review. | Cochrane review supported by NIHR/Cochrane infrastructure; no product sponsor. | Dangerous / do not use Cochrane/PMC |
| Alkaline water or alkaline diets treat cancer. | BMJ Open systematic review found no randomized trials and no studies of alkaline water for cancer treatment. | Canada-led review; global literature. | No specific grant; competing interests declared none. | No evidence BMJ Open |
Text version of this infographic
| Evidence level | Ingredients or approaches | Practical meaning |
|---|---|---|
| Strongest | Fiber-rich foods and whole grains | Best human evidence among ingredients for lower colorectal cancer risk; evidence is strongest for foods, not isolated “cancer fiber” pills. |
| Moderate | Cruciferous vegetables; vitamin D advanced-cancer signal | Use as part of diet or deficiency correction; do not treat them as cancer therapy. |
| Inconclusive | Green tea beverage; sulforaphane capsules | Interesting biology and mixed epidemiology; cancer-prevention proof is not strong enough for supplement claims. |
| Avoid | B17/laetrile, apricot kernels, peroxide, Gerson therapy, Essiac | No good cancer-treatment evidence; several carry serious toxicity or treatment-delay risk. |
The cancer ingredient evidence map
Cancer is a leading cause of death worldwide, and WHO lists tobacco use, high body mass index, alcohol use, low fruit and vegetable intake, and lack of physical activity among major behavioral and dietary risks (WHO cancer fact sheet). IARC classifies processed meat as carcinogenic to humans and red meat as probably carcinogenic to humans, which means ingredient decisions should include what to reduce as well as what to add (IARC red and processed meat evaluation).
The evidence pattern is consistent: foods and dietary patterns have more credible cancer-prevention evidence than isolated “anticancer” supplement capsules. Randomized cancer-prevention trials are difficult because cancer develops over years, but RCTs are still essential when sellers claim a capsule prevents, slows, or treats cancer.
Text version of this infographic
| Category | What it means | Examples | Verdict |
|---|---|---|---|
| Risk reduction | Long-term dietary pattern associated with lower future cancer risk in populations. | Fiber-rich foods, whole grains, vegetables. | Useful as prevention support; not a treatment plan. |
| Treatment claim | A claim that an ingredient shrinks, cures, detoxes, alkalizes, or selectively kills cancer. | B17/laetrile, hydrogen peroxide/oxygen therapies, Gerson therapy. | Requires controlled oncology evidence; unsafe when used instead of proven care. |
Ingredients with the best independent evidence for risk reduction
1. Dietary fiber and whole grains
Verdict: WORKS for colorectal cancer risk reduction as food pattern evidence
Dietary fiber has the strongest ingredient-level cancer-prevention evidence in this review: a BMJ dose-response meta-analysis of prospective studies found RR 0.90 per 10 g/day higher total fiber intake and RR 0.83 per three daily servings of whole grains for colorectal cancer (BMJ fiber meta-analysis). The finding is strongest for cereal fiber and whole grains, while fruit, vegetable, and legume fiber estimates were less precise in that analysis (BMJ fiber meta-analysis).
| Form | Evidence | Best use | Side effects | Interactions | Grade |
|---|---|---|---|---|---|
| Whole grains | Prospective evidence supports lower colorectal cancer risk. | Daily food pattern; replace refined grains when possible. | Gas, bloating, bowel changes if increased rapidly. | Generally food-safe; people with celiac disease must avoid gluten-containing grains. | Strong |
| Cereal fiber / bran foods | BMJ analysis found cereal fiber RR 0.90 per 10 g/day. | Colorectal-risk-reduction dietary pattern. | GI discomfort if increased quickly. | Can reduce absorption of some medicines if taken simultaneously. | Strong |
| Psyllium or isolated fiber supplements | Useful for bowel regularity and cholesterol, but cancer-risk evidence is less direct than whole foods. | Adjunct when food fiber is insufficient; take with adequate fluid. | Gas, bloating, choking risk if taken without water. | Separate from medicines because bulk fiber can reduce absorption. | Moderate for health, indirect for cancer |
2. Cruciferous vegetables and sulforaphane
Verdict: LIKELY HELPFUL AS FOODS; supplements not proven
Cruciferous vegetables include broccoli, Brussels sprouts, cabbage, cauliflower, kale, bok choy, radish, arugula, and mustard greens; they contain glucosinolates that can yield isothiocyanates such as sulforaphane after chopping, chewing, or microbial metabolism (cruciferous vegetable review). A meta-analysis found high cruciferous vegetable intake was inversely associated with colorectal cancer risk, but heterogeneity and observational design keep the grade below “proven supplement” level (cruciferous vegetable meta-analysis).
| Form | What actually does the work | Evidence | Safety / interactions | Grade |
|---|---|---|---|---|
| Broccoli and broccoli sprouts | Glucoraphanin converted to sulforaphane. | Mechanistic and biomarker evidence; no definitive cancer-incidence supplement proof. | GI upset is possible; sprouts can carry foodborne illness risk if improperly handled. | Moderate as food |
| Cabbage, cauliflower, kale, Brussels sprouts | Glucosinolates, indoles, fiber, micronutrients. | Observational inverse association with colorectal cancer risk. | High vitamin K foods require consistent intake for warfarin users; very high raw intake may matter in iodine deficiency. | Moderate |
| Sulforaphane / broccoli sprout extract capsules | Standardized glucoraphanin or sulforaphane precursors. | Biomarker evidence, not proven cancer prevention. | Product composition varies; oncology drug interactions are not fully mapped. | Unproven supplement |
3. Vitamin D
Verdict: MIXED: correct deficiency; do not megadose for cancer prevention
Vitamin D is biologically relevant to cell growth and immune pathways, but supplementation did not reduce total invasive cancer incidence in the VITAL primary trial (VITAL primary trial). A secondary VITAL analysis found vitamin D lowered advanced metastatic or fatal cancer overall, with the strongest signal among normal-weight participants, so the most responsible verdict is “promising for advanced-cancer biology, not proven broad prevention” (VITAL advanced-cancer analysis).
| Form | Evidence for cancer | Best use | Side effects | Interactions | Grade |
|---|---|---|---|---|---|
| Vitamin D3 / cholecalciferol | No lower invasive cancer incidence in VITAL; advanced-cancer signal in secondary analysis. | Correct low vitamin D status and support bone/mineral physiology. | Excess can cause hypercalcemia, nausea, weakness, constipation, kidney stones, and kidney injury. | Use caution with thiazide diuretics, digoxin, high-dose calcium, steroids, orlistat, and bile-acid sequestrants. | Mixed |
| Vitamin D2 / ergocalciferol | Same cancer uncertainty; may be less potent for raising 25(OH)D than D3. | Alternative for deficiency correction when appropriate. | Same toxicity pattern at excessive doses. | Same interaction categories as D3. | Mixed |
| Calcitriol or high-dose protocols | Not a wellness supplement; drug-like risk. | Clinician-directed medical indications only. | Higher hypercalcemia risk. | Requires medication review and calcium monitoring. | Do not self-dose |
4. Green tea and EGCG
Verdict: INCONCLUSIVE; beverage is different from high-dose extract
Green tea contains catechins such as EGCG, but Cochrane found inconsistent results and limited evidence for cancer prevention overall (Cochrane green tea review). High-dose green-tea extract is a safety concern because LiverTox reports clinically apparent acute liver injury, including rare liver failure, transplant, or death (LiverTox green tea).
| Form | Evidence | Safety | Interactions | Grade |
|---|---|---|---|---|
| Brewed green tea | Mixed observational and low-certainty trial evidence. | Caffeine-related insomnia, reflux, palpitations, anxiety in sensitive people. | Caffeine can interact with stimulants; large or inconsistent intake may matter for warfarin users. | Inconclusive |
| EGCG / green-tea extract capsules | No firm cancer-prevention recommendation. | GI effects and liver-enzyme elevations reported in trials; LiverTox documents serious liver injury cases. | Avoid with liver disease or hepatotoxic medicines unless supervised; discuss during chemotherapy. | Higher-risk supplement |
Text version of this infographic
| Ingredient | Food form | Supplement form | Verdict |
|---|---|---|---|
| Fiber | Whole grains and cereal fiber have the strongest colorectal-risk evidence. | Fiber pills have more indirect cancer evidence. | Prefer food-first fiber. |
| Cruciferous vegetables | Broccoli, cabbage, kale, and related vegetables have observational support. | Sulforaphane capsules rely mostly on biomarker evidence. | Prefer cruciferous vegetables as foods. |
| Vitamin D | Food and sunlight contribute to status, but status varies by person. | Supplementation corrects deficiency; megadosing is not proven for broad cancer prevention. | Test and treat deficiency clinically. |
| Green tea | Brewed tea evidence is inconclusive. | EGCG extract has liver-safety concerns. | Avoid high-dose extracts without medical supervision. |
Popular cancer ingredients that are unproven, debunked, or dangerous
Laetrile, amygdalin, vitamin B17, and apricot kernels
Laetrile/amygdalin is promoted under names such as “vitamin B17,” but Cochrane found no RCT or quasi-RCT evidence supporting it as cancer treatment and concluded the risk-benefit balance is unambiguously negative because of cyanide poisoning risk (Cochrane laetrile review). NCI reports no controlled clinical trial of laetrile and lists cyanide-like toxicity including liver damage, nerve damage, coma, and death (NCI laetrile PDQ).
High-dose intravenous vitamin C
High-dose IV vitamin C remains experimental in oncology: NCI states that early observations appeared promising but had important trial-design limitations, and that early randomized placebo-controlled trials using oral vitamin C did not show benefit in advanced cancer (NCI intravenous vitamin C PDQ). The clinical risk is not only toxicity; the larger risk is substituting an unproven infusion protocol for evidence-based oncology treatment.
Essiac and Flor Essence teas
Essiac and Flor Essence are proprietary herbal tea mixtures, and NCI states that no controlled human data show they are effective for cancer patients (NCI Essiac/Flor Essence PDQ). NCI also notes that some evidence suggested Flor Essence may increase tumor formation in an animal model of breast cancer, which makes “it is natural, so it cannot hurt” an unsafe assumption (NCI Essiac/Flor Essence PDQ).
Gerson therapy and coffee enemas
Gerson therapy combines a restrictive diet, supplements, pancreatic enzymes, and repeated coffee or other enemas; NCI states that no conclusions about effectiveness as an adjuvant or cure can be drawn from the reported studies (NCI Gerson PDQ). NCI reports case concerns including three deaths that seemed related to coffee enemas, with two attributed to electrolyte imbalance and one patient having polymicrobial septicemia after treatment at a Gerson clinic (NCI Gerson PDQ).
Graviola / soursop
Graviola is marketed online as an anticancer botanical, but Memorial Sloan Kettering Cancer Center states there is no proof it benefits cancer patients and that human studies are lacking despite cell-line findings (MSKCC graviola). MSKCC also flags uncertainty about whether neurotoxicity seen in preclinical studies translates to humans, which is enough to avoid cancer-treatment claims (MSKCC graviola).
Alkaline water and alkaline diets
The alkaline-water cancer claim is a chemistry-sounding story without clinical proof: a BMJ Open systematic review found no randomized trials and no studies examining alkaline water for cancer treatment (BMJ Open alkaline-water review). The same review concluded there is almost no actual research to support or disprove alkaline diet or alkaline water claims for cancer initiation or treatment (BMJ Open alkaline-water review).
Hydrogen peroxide and “oxygen” therapies
Hydrogen peroxide and other “hyperoxygenation” therapies are based on the erroneous idea that cancer is caused by oxygen deficiency, according to a CA: A Cancer Journal for Clinicians review indexed in PubMed (hydrogen peroxide review). A Memorial Sloan Kettering–authored PubMed review states that oxygen therapies have no scientific evidence supporting cancer-cure claims and have caused serious adverse events and deaths (oxygen therapies review).
Text version of this infographic
| Remedy | Main evidence problem | Main risk |
|---|---|---|
| B17 / apricot kernels | No controlled clinical evidence for cancer treatment. | Cyanide poisoning, coma, death. |
| Hydrogen peroxide | No scientific evidence supporting cancer-cure claims. | Poisoning, gas embolism, serious adverse events, death. |
| Gerson therapy | No reliable conclusion about cancer effectiveness. | Electrolyte imbalance, infection, deaths, treatment delay. |
| Essiac / Flor Essence | No controlled human efficacy data for cancer. | False reassurance; possible product variability and adverse effects. |
| Graviola / soursop | Cell-line evidence without human proof. | Neurotoxicity concerns and treatment delay. |
| Alkaline water | No treatment trials found in systematic review. | False reassurance and wasted time. |
What works and what does not
| Claimed benefit | Verdict | Evidence | Key caveat |
|---|---|---|---|
| Lower colorectal cancer risk with fiber/whole grains | WORKS | Prospective meta-analysis with dose response. | Food pattern evidence; not a treatment for existing cancer. |
| Lower colorectal cancer risk with cruciferous vegetables | LIKELY HELPFUL | Observational meta-analysis plus plausible glucosinolate biology. | Not proof that sulforaphane capsules prevent cancer. |
| Prevent cancer with vitamin D supplements | MIXED | VITAL null for invasive cancer; secondary advanced-cancer signal. | Correct deficiency; avoid megadosing. |
| Prevent cancer with green tea / EGCG | INSUFFICIENT | Cochrane found inconsistent, low-certainty evidence. | High-dose extracts can injure the liver. |
| Slow or treat cancer with curcumin | DOES NOT HAVE PROOF | Systematic review of RCTs did not support blocking or slowing cancer progression. | May interact with anticoagulants or treatment plans; supplement bioavailability claims are often commercial. |
| Prevent cancer with omega-3 supplements | DOESN'T | 47-RCT meta-analysis found little or no effect on cancer diagnosis or cancer death. | Omega-3 may have other indications, but cancer prevention is not one. |
| Treat cancer with laetrile/B17/apricot kernels | DANGEROUS | Cochrane found no supportive RCT evidence and cyanide poisoning risk. | Avoid entirely. |
| Treat cancer with alkaline water | NO EVIDENCE | Systematic review found no treatment studies. | Do not use pH claims to delay care. |
| Treat cancer with Gerson, Essiac, graviola, or peroxide | AVOID AS TREATMENT | NCI, MSKCC, and PubMed reviews find no adequate treatment evidence and safety concerns. | Especially dangerous when substituted for oncology treatment. |
Side effects and interactions
People in active cancer treatment should treat supplements like medication exposures because herbs, vitamins, antioxidants, and concentrated extracts may interfere with chemotherapy, radiation, anticoagulation, anesthesia, immunotherapy, or clinical-trial eligibility (NCCIH cancer and complementary approaches, NCI CAM overview). The interaction table below is not a substitute for an oncology pharmacist review.
| Ingredient | Common side effects | Rare but serious risks | Common interaction concerns | Who should be extra cautious | Source |
|---|---|---|---|---|---|
| Fiber / psyllium | Gas, bloating, cramps, bowel changes. | Choking or obstruction if taken dry or with too little fluid. | May reduce absorption of medicines if taken at the same time; separate from oral drugs when possible. | Swallowing disorders, bowel obstruction risk, severe constipation, strict fluid restriction. | BMJ |
| Cruciferous vegetables / sulforaphane | Gas, bloating, taste intolerance. | Foodborne illness risk from raw sprouts; theoretical thyroid concerns with very high raw intake in iodine deficiency. | High vitamin K foods require consistency with warfarin; supplement interactions with oncology drugs are incompletely studied. | Warfarin users, people with thyroid disease, immunocompromised people using raw sprouts. | PMC review |
| Vitamin D | Nausea, constipation, weakness, thirst, frequent urination when excessive. | Hypercalcemia, kidney stones, kidney injury, arrhythmia risk in susceptible people. | Thiazide diuretics can raise hypercalcemia risk; digoxin toxicity risk rises with hypercalcemia; orlistat and bile-acid sequestrants can reduce absorption; steroids can reduce vitamin D effects. | Kidney disease, granulomatous disease, hyperparathyroidism, history of stones, digoxin users. | NIH ODS |
| Green tea beverage / EGCG extract | Caffeine effects, reflux, insomnia, nausea. | Green-tea extract can cause clinically apparent liver injury, rarely liver failure or transplant. | Caffeine-stimulant interactions; possible warfarin concern with high/inconsistent intake; avoid stacking with other hepatotoxic supplements or drugs unless supervised. | Liver disease, heavy alcohol use, pregnancy, anticoagulant users, people on hepatotoxic medicines. | LiverTox |
| Curcumin / turmeric extract | Nausea, reflux, stomach upset, diarrhea, constipation. | Turmeric products have been implicated in clinically apparent acute liver injury. | Potential bleeding concern with anticoagulants/antiplatelets; may affect diabetes medicines and perioperative bleeding planning; oncology interactions are not fully mapped. | Liver disease, gallbladder disease, anticoagulant users, people before surgery or invasive biopsy. | NCCIH / LiverTox |
| Omega-3 EPA/DHA | Fishy burps, nausea, loose stools, reflux. | High-dose products may increase atrial fibrillation risk in some trials and may affect bleeding tendency. | Use caution with anticoagulants, antiplatelets, surgery, bleeding disorders, and multiple blood-thinning supplements. | Fish/shellfish allergy, atrial fibrillation history, bleeding risk, planned surgery. | NIH ODS |
| Laetrile / B17 / apricot kernels | Nausea, vomiting, headache, dizziness. | Cyanide poisoning, liver damage, nerve injury, coma, death. | Vitamin C and certain dietary patterns may worsen cyanide risk in laetrile users according to the Cochrane review. | Everyone; avoid entirely. | Cochrane/PMC |
| Gerson therapy / coffee enemas | Diarrhea, dehydration, weakness, cramping. | Electrolyte imbalance, infection, septicemia, deaths reported in case literature summarized by NCI. | Can destabilize electrolytes and interfere with treatment nutrition plans. | Everyone with cancer; especially kidney disease, heart disease, frailty, diarrhea, neutropenia. | NCI PDQ |
Text version of this infographic
| Checkpoint | Why it matters | Examples |
|---|---|---|
| Blood thinners | Some supplements may affect bleeding risk or vitamin K consistency. | Warfarin, DOACs, aspirin, clopidogrel. |
| Cancer therapies | Supplements can interfere with chemotherapy, radiation, immunotherapy, or clinical trials. | Antioxidant megadoses, botanicals, unknown extracts. |
| Liver/kidney risks | Concentrated extracts and megadoses can injure detoxification and excretion pathways. | EGCG extract, curcumin extract, vitamin D megadoses. |
| Surgery/procedures | Bleeding, electrolytes, fasting status, and anesthesia interactions matter. | Omega-3 high dose, curcumin, coffee enemas. |
Funding and conflict review
| Source | Independence rating | Credibility rank | Money trail / influence check | Why it may be reliable |
|---|---|---|---|---|
| BMJ fiber and whole-grain meta-analysis | Independent | Very strong | Funded by World Cancer Research Fund; authors declared no financial relationships with interested organizations. | Transparent protocol, dose-response methods, prospective cohorts, and reputational risk for BMJ and WCRF. |
| Cruciferous vegetable colorectal-cancer meta-analysis | Probably independent | Strong | Public academic and NIH-linked training funding; authors declared no conflicts. | Peer-reviewed methods and no direct supplement-company upside found. |
| VITAL vitamin D primary trial | Partly conflicted but high-quality | Strong | NIH-funded; vitamin D/placebo materials donated by Pharmavite and packaging support disclosed. | Large randomized placebo-controlled design; null primary result reduces concern that donation drove a positive marketing result. |
| Cochrane green tea review | Probably independent review; included trials vary | Strong | Review summarized mixed trial sponsorship, including public, charity, and some pharmaceutical/company funding. | Cochrane methods explicitly graded uncertainty and did not overstate benefits. |
| Omega-3 randomized-trial meta-analysis | Independent | Very strong | Commissioned and funded by WHO NUGAG; authors reported no interested-organization relationships. | Large RCT evidence base and transparent WHO-guideline purpose. |
| Curcumin cancer RCT review | Independent | Strong | No external funding; authors declared no conflict of interest. | Directly assessed hard cancer endpoints and concluded against efficacy despite popular interest. |
| Cochrane laetrile review | Independent | Very strong | Supported by NIHR/Cochrane infrastructure; no product sponsor. | Strong negative conclusion matches NCI clinical-trial history and toxicity evidence. |
| NCI PDQ Gerson summary | Independent government editorial review | Strong | Public cancer-information program; PDQ summaries are literature reviews, not product marketing. | Institutional accountability and explicit adverse-event reporting. |
| BMJ Open alkaline-water review | Independent | Strong | No specific grant; competing interests none declared. | Systematic methods found evidence gaps rather than manufacturing a conclusion. |
Frequently asked questions
What supplement is proven to prevent cancer?
No supplement in this review is proven to broadly prevent cancer. The strongest ingredient-level evidence is for dietary fiber and whole grains lowering colorectal cancer risk as part of a food pattern, not as a cancer-treatment capsule (BMJ fiber meta-analysis).
Can sulforaphane or broccoli sprouts treat cancer?
No. Cruciferous vegetables are reasonable foods in a cancer-prevention diet, and sulforaphane has plausible mechanisms, but human cancer-treatment or cancer-incidence proof for sulforaphane supplements is not established (cruciferous vegetable review).
Should people with cancer take vitamin D?
Vitamin D should be used to correct deficiency or support bone/mineral health when clinically appropriate, not as a standalone cancer treatment. VITAL found no significant reduction in invasive cancer incidence, while a secondary analysis found a lower rate of advanced cancer, so dosing should be individualized and monitored (VITAL primary trial, VITAL advanced-cancer analysis).
Is green tea safe during cancer treatment?
Brewed green tea is not the same as concentrated EGCG extract. Green-tea extract has been linked to liver injury in LiverTox, and NCCIH advises people with cancer to consult their health care providers before adding supplements or complementary approaches (LiverTox green tea, NCCIH cancer and complementary approaches).
Does curcumin fight cancer?
Curcumin has extensive laboratory interest but limited human cancer evidence. A systematic review of randomized cancer trials concluded that curcumin is not effective in blocking or slowing cancer progression based on available hard-endpoint evidence (curcumin RCT review).
Do omega-3 supplements reduce cancer risk?
No convincing randomized evidence supports omega-3 supplements for cancer prevention. A 47-trial meta-analysis found long-chain omega-3 had little or no effect on cancer diagnosis or cancer death (omega-3 randomized-trial meta-analysis).
Is vitamin B17 the same as laetrile or apricot kernels?
“Vitamin B17” is a marketing name commonly used for amygdalin/laetrile-related products, including apricot-kernel products. Cochrane found no supportive RCT evidence for cancer treatment and warned about cyanide poisoning risk (Cochrane laetrile review).
Does alkaline water kill cancer cells?
No human treatment evidence supports alkaline water as cancer therapy. A BMJ Open systematic review found no randomized trials and no studies of alkaline water for cancer treatment (BMJ Open alkaline-water review).
Why are testimonials not enough for cancer remedies?
Cancer outcomes can be affected by diagnosis accuracy, stage, concurrent treatment, imaging timing, tumor biology, and spontaneous symptom changes. NCI notes that anecdotal and case reports for laetrile provide little evidence because of mixed conventional therapies, variable dose and duration, and inconsistent documentation (NCI laetrile PDQ).
What should a patient do before taking any supplement during cancer care?
Bring the exact product label, dose, frequency, and reason for use to the oncology team or oncology pharmacist. NCCIH warns that some complementary approaches can interfere with cancer treatment and says people diagnosed with cancer should consult health care providers before using them (NCCIH cancer and complementary approaches).
Sources
- Aune D, Chan DSM, Lau R, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011. https://www.bmj.com/content/343/bmj.d6617
- Wu QJ, Yang Y, Vogtmann E, et al. Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Annals of Oncology. 2013. https://pmc.ncbi.nlm.nih.gov/articles/PMC3603442/
- Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacological Research. 2007. https://pmc.ncbi.nlm.nih.gov/articles/PMC2737735/
- Manson JE, Cook NR, Lee IM, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. New England Journal of Medicine. 2019. https://pubmed.ncbi.nlm.nih.gov/30415629/
- Chandler PD, Chen WY, Ajala ON, et al. Effect of Vitamin D3 Supplements on Development of Advanced Cancer. JAMA Network Open. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7675103/
- NIH Office of Dietary Supplements. Vitamin D — Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
- Filippini T, Malavolti M, Borrelli F, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database of Systematic Reviews. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7059963/
- LiverTox. Green Tea. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK547925/
- Baldi A, De Luca C. Exploring the Contribution of Curcumin to Cancer Therapy: A Systematic Review of Randomized Controlled Trials. Pharmaceutics. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10144810/
- NCCIH. Turmeric: Usefulness and Safety. https://www.nccih.nih.gov/health/turmeric
- LiverTox. Turmeric. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK548561/
- Hanson S, Thorpe G, Winstanley L, et al. Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials. British Journal of Cancer. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7156752/
- NIH Office of Dietary Supplements. Omega-3 Fatty Acids — Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
- Milazzo S, Horneber M. Laetrile treatment for cancer. Cochrane Database of Systematic Reviews. 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC6513327/
- NCI PDQ. Laetrile/Amygdalin. https://www.cancer.gov/about-cancer/treatment/cam/hp/laetrile-pdq
- NCI PDQ. Intravenous Vitamin C. https://www.cancer.gov/about-cancer/treatment/cam/hp/vitamin-c-pdq
- NCI PDQ. Essiac/Flor Essence. https://www.cancer.gov/about-cancer/treatment/cam/hp/essiac-pdq
- NCI PDQ. Gerson Therapy. https://www.cancer.gov/about-cancer/treatment/cam/hp/gerson-pdq
- Memorial Sloan Kettering Cancer Center. Graviola. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/graviola
- Fenton TR, Huang T. Systematic review of the association between dietary acid load, alkaline water and cancer. BMJ Open. 2016. https://pmc.ncbi.nlm.nih.gov/articles/PMC4916623/
- Green S. Questionable methods of cancer management: hydrogen peroxide and other “hyperoxygenation” therapies. CA: A Cancer Journal for Clinicians. 1993. https://pubmed.ncbi.nlm.nih.gov/8422605/
- Cassileth B. Oxygen therapies. Oncology. 2009. https://pubmed.ncbi.nlm.nih.gov/20043470/
- NCCIH. Cancer and Complementary Health Approaches: What You Need To Know. https://www.nccih.nih.gov/health/cancer-and-complementary-health-approaches-what-you-need-to-know
- NCI. Complementary and Alternative Medicine. https://www.cancer.gov/about-cancer/treatment/cam
- WHO. Cancer fact sheet. https://www.who.int/news-room/fact-sheets/detail/cancer
- IARC. IARC Monographs evaluate consumption of red meat and processed meat. https://www.iarc.who.int/wp-content/uploads/2018/07/pr240_E.pdf